Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. N-pyridazin-3-yl-4-(3-((5-(trifluoromethyl)pyridin-2-yl)oxy)benzylidene)piperidine-1-carboxamide
2. Pf 04457845
3. Pf-04457845
4. Pf04457845
1. Pf-04457845
2. 1020315-31-4
3. Pf 04457845
4. Pf04457845
5. H4c81m8yyw
6. Chembl1651534
7. 1-piperidinecarboxamide, N-3-pyridazinyl-4-((3-((5-(trifluoromethyl)-2-pyridinyl)oxy)phenyl)methylene)-
8. 1-piperidinecarboxamide, N-3-pyridazinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methylene]-
9. N-pyridazin-3-yl-4-((3-(5-(trifluoromethyl)pyridin-2-yl)oxyphenyl)methylidene)piperidine-1-carboxamide
10. N-pyridazin-3-yl-4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzylidene)piperidine-1-carboxamide
11. N-pyridazin-3-yl-4-[(3-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl)methylidene]piperidine-1-carboxamide
12. 1-piperidinecarboxamide, N-3-pyridazinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methylene]-;1-piperidinecarboxamide, N-3-pyridazinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methylene]-
13. N-(pyridazin-3-yl)-4-[(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}phenyl)methylidene]piperidine-1-carboxamide
14. Unii-h4c81m8yyw
15. Compound 23 [pmid: 21666860]
16. Gtpl6694
17. Schembl1010408
18. Dtxsid00144539
19. Bcp05805
20. Ex-a2309
21. Bdbm50335377
22. Mfcd18782721
23. S2421
24. Zinc66111849
25. Akos027338651
26. Cs-0868
27. Db12012
28. Sb17493
29. Ncgc00378983-01
30. Ncgc00378983-03
31. Ac-36022
32. As-74797
33. Hy-14376
34. Pf-4457845
35. A855972
36. Pf-04457845, >=98% (hplc)
37. Q7119045
38. N-3-pyridazinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methylene]-1-piperidinecarboxamide
39. N-pyridazin-3-yl-4-[[3-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methylidene]piperidine-1-carboxami
| Molecular Weight | 455.4 g/mol |
|---|---|
| Molecular Formula | C23H20F3N5O2 |
| XLogP3 | 3.3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 4 |
| Exact Mass | 455.15690938 g/mol |
| Monoisotopic Mass | 455.15690938 g/mol |
| Topological Polar Surface Area | 80.2 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 680 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
55
PharmaCompass offers a list of PF-04457845 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right PF-04457845 manufacturer or PF-04457845 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred PF-04457845 manufacturer or PF-04457845 supplier.
PharmaCompass also assists you with knowing the PF-04457845 API Price utilized in the formulation of products. PF-04457845 API Price is not always fixed or binding as the PF-04457845 Price is obtained through a variety of data sources. The PF-04457845 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A PF 04457845 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of PF 04457845, including repackagers and relabelers. The FDA regulates PF 04457845 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. PF 04457845 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A PF 04457845 supplier is an individual or a company that provides PF 04457845 active pharmaceutical ingredient (API) or PF 04457845 finished formulations upon request. The PF 04457845 suppliers may include PF 04457845 API manufacturers, exporters, distributors and traders.
PF 04457845 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of PF 04457845 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right PF 04457845 GMP manufacturer or PF 04457845 GMP API supplier for your needs.
A PF 04457845 CoA (Certificate of Analysis) is a formal document that attests to PF 04457845's compliance with PF 04457845 specifications and serves as a tool for batch-level quality control.
PF 04457845 CoA mostly includes findings from lab analyses of a specific batch. For each PF 04457845 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
PF 04457845 may be tested according to a variety of international standards, such as European Pharmacopoeia (PF 04457845 EP), PF 04457845 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (PF 04457845 USP).
